Novo CEO pressed by Senate to cut rates of obesity, diabetes medications CEO Lars Fruergaard Jørgensen advised lawmakers the organization would think about new talks with insurers in regards to the list costs of Wegovy and copyright whenever they pledge to maintain the medicines on their own formularies. Sanders quickly https://andresmduka.shoutmyblog.com/30091099/everything-about-healthcare-news